医学
药效学
药代动力学
抗菌剂
人口
药品
重症监护医学
药理学
环境卫生
微生物学
生物
作者
Kensuke Shoji,Jumpei Saito,Hidefumi Nakamura,Kazuaki Matsumoto,Kazutaka Oda,Yoshio Takesue,Isao Miyairi
出处
期刊:Pediatric Infectious Disease Journal
[Ovid Technologies (Wolters Kluwer)]
日期:2022-07-28
卷期号:41 (10): e418-e423
标识
DOI:10.1097/inf.0000000000003622
摘要
Pharmacologic knowledge is important for pediatricians conducting feasible pharmacokinetic or pharmacodynamic (PK/PD) studies or applying effective antimicrobial therapies in children. Because of the difficulties in conducting PK/PD studies in children, antimicrobial PK/PD data in children are still limited. To fill in the lack of knowledge, promotion of population PK/PD analysis, which allows us to handle sparse sampling data from individual patients, is important because it is considered a suitable methodology to conduct PK/PD studies in children with limited blood drug concentration data for PK/PD analysis. Population PK/PD analysis is also useful in the clinical setting to provide individualized optimal dosage for each patient with various conditions. Here we summarized the current aspects of pediatric PK/PD studies of antimicrobials in Japan from clinical and research perspectives, specifically focusing on the importance of population PK/PD analysis.
科研通智能强力驱动
Strongly Powered by AbleSci AI